Structure based drug design and LIE models for GPCRs
|
|
- Charity Carroll
- 5 years ago
- Views:
Transcription
1 Structure based drug design and LIE models for GPCRs Peter Kolb Shoichet Lab ACS 237 th National Meeting, March 24, 2009 p.1/26
2 [Acknowledgements] Brian Shoichet John Irwin Mike Keiser Brian Kobilka Daniel Rosenbaum Juan José Fung Jérôme Hert Jonathan Mason NIH Anne Marie Jørgensen ACS 237 th National Meeting, March 24, 2009 p.2/26
3 [utline] The β 2 -adrenergic receptor LIECE Docking against β 2 AR Ligands Ligand Efficacy The approach Earlier examples LIECE for β-adrenergic receptors Conclusions ACS 237 th National Meeting, March 24, 2009 p.3/26
4 [ββ 2 AR xtal structure] T4-lysozyme (for stability) Cerezov et al., Science 318: Rosenbaum et al., Science 318: ACS 237 th National Meeting, March 24, 2009 p.4/26
5 [ββ 2 AR xtal structure] binding site T4-lysozyme (for stability) Cerezov et al., Science 318: Rosenbaum et al., Science 318: ACS 237 th National Meeting, March 24, 2009 p.4/26
6 [ββ 2 AR xtal structure] binding site T4-lysozyme (for stability) Cerezov et al., Science 318: Rosenbaum et al., Science 318: ACS 237 th National Meeting, March 24, 2009 p.4/26
7 [AA beautiful binding site] ACS 237 th National Meeting, March 24, 2009 p.5/26
8 [AA beautiful binding site (2)] ACS 237 th National Meeting, March 24, 2009 p.6/26
9 [AA beautiful binding site (2)] F W S H H 2 N N D V ACS 237 th National Meeting, March 24, 2009 p.6/26
10 [Docking] Calculations were done with DCK Docking spheres where distributed based on the positions of the heavy atoms of carazolol and slightly altered to achieve more uniform coverage. The T4-lysozyme insertion was removed, as it carried a net charge of +9. We docked the lead-like subset of the ZINC database, which contains about 1M molecules. DCKING ACS 237 th National Meeting, March 24, 2009 p.7/26
11 [What we predicted] Four classes of substrates have been predicted: classic compounds with all canonical pharmacophoric features of antagonists. bridge compounds connecting the two walls of the binding pocket (Thr195 to Tyr308). sulfonamide compounds. others. We managed to acquire 12, 9, 2 and 2 compounds of each class, respectively. ACS 237 th National Meeting, March 24, 2009 p.8/26
12 [Results] Classic compounds: 4 hits. Bridge compounds: 0 hits. Sulfonamides: 0 hits. thers: 2 hits. 6 hits out of 25 tested 24% hit rate ACS 237 th National Meeting, March 24, 2009 p.9/26
13 [The six hits] Me Et Me H Me 1 H 2 N + Me Me µm rank 6 N S N + Me µm µm rank 97 rank 156 H N + H N + Me N + H H 2 H µm µm µm rank 37 rank 42 rank 104 Me N + H 2 Et Kolb et al. PNAS, accepted. ACS 237 th National Meeting, March 24, 2009 p.10/26
14 [The six hits] Me Et Me H Me 1 H 2 N + Me Me µm rank 6 N S N + Me µm µm rank 97 rank 156 H N + H 2 N + H 2 Me 2.0 µm µm rank 37 rank 42 N + H 2 Me H 4 N + H µm rank 104 Et Kolb et al. PNAS, accepted. ACS 237 th National Meeting, March 24, 2009 p.10/26
15 [For comparison: five β 2 antagonists] H H 2 N+ HN H N + H 2 HN N + H 2 H ICI Carvedilol Carazolol F 3 C N N CH 3 H N + H 2 H N H 2 H + N H2 CGP 20712A Alprenolol ACS 237 th National Meeting, March 24, 2009 p.11/26
16 [The hits are all inverse agonists] ACS 237 th National Meeting, March 24, 2009 p.12/26
17 [The search for hay in a haystack] LGICs β-lactamase β 2 AR proteases kinases GPCRs % of library with significant assignment number of molecules with significant assignment ACS 237 th National Meeting, March 24, 2009 p.13/26
18 LIECE ACS 237 th National Meeting, March 24, 2009 p.14/26
19 [Ranking compounds: LIECE] Linear Interaction Energy using Continuum Electrostatics (Huang and Caflisch, J Med Chem 47: ). G bind α E vdw + β E elec + γ E E elec = E complex (E protein + E ligand ) by CHARMM. = E coul + G solv G solv is calculated with the PBEQ solver in CHARMM. Known inhibitors are needed to calibrate α,β and γ. Minimisation to a native like conformation Energy evaluation with solvation ACS 237 th National Meeting, March 24, 2009 p.15/26
20 [riginal study: proteases] protein α β β-secretase standard deviation ± ± HIV1-PR standard deviation ± ± Two proteases, yet clearly different coefficients parameters are not transferable, right? ACS 237 th National Meeting, March 24, 2009 p.16/26
21 [The human kinome] ACS 237 th National Meeting, March 24, 2009 p.17/26
22 [LIECE for kinases] protein α β CDK standard deviation ± ± Lck standard deviation ± ± P standard deviation ± ± For kinases, parameters seem to be transferable. Consequently, we tried to derive a universal model. ACS 237 th National Meeting, March 24, 2009 p.18/26
23 [LIECE for kinases (2)] -5 LIECE model for kinases 165 compounds; 3 different X-ray structures -5 Prediction for EphB4 37 compounds; RMSE=1.30 kcal/mol -5 Prediction for EGFR 128 compounds; RMSE=1.42 kcal/mol cpds in 1ke5 (CDK2) 51 cpds in 1qpe (lck) 41 cpds in 1m7q (p38) LIECE prediction exp G exp G exp G G calc = E vdw ( E coul + G solv ) Kolb et al. J Med Chem 51: ACS 237 th National Meeting, March 24, 2009 p.19/26
24 enzymatic assays cell-based assay [Kinase hits] compound structure MW IC 50 IC 50 IC 50 CH predicted G [Da] [µm] [µm] [µm] % [kcal mol 1 ] H 2N S NH NH n.d. n.d. n.d HN N N N N R R= 2 (CH 2 ) 4 H , , 7.9 neg (CH 2 ) 3 CH , n.d. neg (CH 2 ) 2 CH n.d. n.d. neg. 5 ortho-methoxy-phenyl n.d. n.d. 20 µm 6 (CH 2 ) 3 CH n.d. n.d. 20 µm 7 (CH 2 ) 2 Ph µm e n.d. n.d. 20 µm 8 (CH 2 ) 2 -meta-methylphenyl µm e n.d. n.d. 20 µm ACS 237 th National Meeting, March 24, 2009 p.20/26
25 LIECE for GPCRs ACS 237 th National Meeting, March 24, 2009 p.21/26
26 [What we used for β 2 AR] 7 ligands, all enantiopure, from Dallanoce et al., BMC 14, ligands that belong to the well-known set of antagonists (all S) and are described in Baker et al. Issues on the ligand side: R chirality conformational flexibility N * * NHt Bu different efficacies H ACS 237 th National Meeting, March 24, 2009 p.22/26
27 [LIECE for β 2 AR] -6-8 fitting compounds G pred = E vdw calculated G E coul G solv RMSE q 2 = = 1.23 kcal/mol experimental G ACS 237 th National Meeting, March 24, 2009 p.23/26
28 [Looks nice, but... ] fitting compounds 6 hits 4 G pred = E vdw calculated G E coul G solv RMSE q 2 = = 2.24 kcal/mol experimental G ACS 237 th National Meeting, March 24, 2009 p.24/26
29 [AA combined model for β 1 AR and β 2 AR] calculated G fitting compounds hits G pred = E vdw E coul G solv q 2 = RMSE = 1.40 kcal/mol RMSE = 1.75 kcal/mol experimental G ACS 237 th National Meeting, March 24, 2009 p.25/26
30 [Some thoughts at the end] Docking to the β 2 -adrenergic receptor worked nicely we get a high hit rate (24 %) with one potent binder.... we see two previously unexplored scaffolds.... some of it is due to the bias in present-day libraries. LIECE models for GPCRs are difficult because the receptors are rather flexible and there are at least two distinct states (activated/inactivated) rigid receptor.... most molecules are chiral and flexible. We get reasonably predictive models, however. VdW is still the most important contribution, but electrostatics is similar. ACS 237 th National Meeting, March 24, 2009 p.26/26
Supporting Information
Discovery of kinase inhibitors by high-throughput docking and scoring based on a transferable linear interaction energy model Supporting Information Peter Kolb, Danzhi Huang, Fabian Dey and Amedeo Caflisch
More informationStructural biology and drug design: An overview
Structural biology and drug design: An overview livier Taboureau Assitant professor Chemoinformatics group-cbs-dtu otab@cbs.dtu.dk Drug discovery Drug and drug design A drug is a key molecule involved
More informationComputational chemical biology to address non-traditional drug targets. John Karanicolas
Computational chemical biology to address non-traditional drug targets John Karanicolas Our computational toolbox Structure-based approaches Ligand-based approaches Detailed MD simulations 2D fingerprints
More informationIntroduction. OntoChem
Introduction ntochem Providing drug discovery knowledge & small molecules... Supporting the task of medicinal chemistry Allows selecting best possible small molecule starting point From target to leads
More informationDrug binding and subtype selectivity in G-protein-coupled receptors
Drug binding and subtype selectivity in G-protein-coupled receptors Albert C. Pan The Aspect of Time in Drug Design Schloss Rauischholzhausen Marburg, Germany Thursday, March 27 th, 2014 D. E. Shaw Research
More informationLigand-receptor interactions
University of Silesia, Katowice, Poland 11 22 March 2013 Ligand-receptor interactions Dr. Pavel Polishchuk A.V. Bogatsky Physico-Chemical Institute of National Academy of Sciences of Ukraine Odessa, Ukraine
More informationMM-GBSA for Calculating Binding Affinity A rank-ordering study for the lead optimization of Fxa and COX-2 inhibitors
MM-GBSA for Calculating Binding Affinity A rank-ordering study for the lead optimization of Fxa and COX-2 inhibitors Thomas Steinbrecher Senior Application Scientist Typical Docking Workflow Databases
More informationVirtual screening in drug discovery
Virtual screening in drug discovery Pavel Polishchuk Institute of Molecular and Translational Medicine Palacky University pavlo.polishchuk@upol.cz Drug development workflow Vistoli G., et al., Drug Discovery
More informationUser Guide for LeDock
User Guide for LeDock Hongtao Zhao, PhD Email: htzhao@lephar.com Website: www.lephar.com Copyright 2017 Hongtao Zhao. All rights reserved. Introduction LeDock is flexible small-molecule docking software,
More informationStructure-based maximal affinity model predicts small-molecule druggability
Structure-based maximal affinity model predicts small-molecule druggability Alan Cheng alan.cheng@amgen.com IMA Workshop (Jan 17, 2008) Druggability prediction Introduction Affinity model Some results
More informationDevelopment of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining
Development of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining Samer Haidar 1, Zouhair Bouaziz 2, Christelle Marminon 2, Tiomo Laitinen 3, Anti Poso
More informationLarge Scale FEP on Congeneric Ligand Series Have Practical Free Energy Calculations arrived at Last?
Large Scale FEP on Congeneric Ligand Series Have Practical Free Energy Calculations arrived at Last? Thomas Steinbrecher, Teng Lin, Lingle Wang, Goran Krilov, Robert Abel, Woody Sherman, Richard Friesner
More informationIs quantum mechanics necessary for predicting binding free energy?
Supporting Information Is quantum mechanics necessary for predicting binding free energy? Ting Zhou, Danzhi Huang and Amedeo Caflisch* Department of Biochemistry, University of Zürich, Winterthurerstrasse
More informationHit Finding and Optimization Using BLAZE & FORGE
Hit Finding and Optimization Using BLAZE & FORGE Kevin Cusack,* Maria Argiriadi, Eric Breinlinger, Jeremy Edmunds, Michael Hoemann, Michael Friedman, Sami Osman, Raymond Huntley, Thomas Vargo AbbVie, Immunology
More informationThe PhilOEsophy. There are only two fundamental molecular descriptors
The PhilOEsophy There are only two fundamental molecular descriptors Where can we use shape? Virtual screening More effective than 2D Lead-hopping Shape analogues are not graph analogues Molecular alignment
More informationGyörgy M. Keserű H2020 FRAGNET Network Hungarian Academy of Sciences
Fragment based lead discovery - introduction György M. Keserű H2020 FRAGET etwork Hungarian Academy of Sciences www.fragnet.eu Hit discovery from screening Druglike library Fragment library Large molecules
More informationDocking. GBCB 5874: Problem Solving in GBCB
Docking Benzamidine Docking to Trypsin Relationship to Drug Design Ligand-based design QSAR Pharmacophore modeling Can be done without 3-D structure of protein Receptor/Structure-based design Molecular
More informationIntroduction to FBDD Fragment screening methods and library design
Introduction to FBDD Fragment screening methods and library design Samantha Hughes, PhD Fragments 2013 RSC BMCS Workshop 3 rd March 2013 Copyright 2013 Galapagos NV Why fragment screening methods? Guess
More informationData Quality Issues That Can Impact Drug Discovery
Data Quality Issues That Can Impact Drug Discovery Sean Ekins 1, Joe Olechno 2 Antony J. Williams 3 1 Collaborations in Chemistry, Fuquay Varina, NC. 2 Labcyte Inc, Sunnyvale, CA. 3 Royal Society of Chemistry,
More informationVirtual Screening in Drug Discovery
Virtual Screening in Drug Discovery edited by Juan Alvarez and Brian Shoichet Taylor &. Francis Taylor & Francis Group Boca Raton London New York Singapore A CRC title, part of the Taylor & Francis imprint,
More informationBUDE. A General Purpose Molecular Docking Program Using OpenCL. Richard B Sessions
BUDE A General Purpose Molecular Docking Program Using OpenCL Richard B Sessions 1 The molecular docking problem receptor ligand Proteins typically O(1000) atoms Ligands typically O(100) atoms predicted
More informationVirtual Screening: How Are We Doing?
Virtual Screening: How Are We Doing? Mark E. Snow, James Dunbar, Lakshmi Narasimhan, Jack A. Bikker, Dan Ortwine, Christopher Whitehead, Yiannis Kaznessis, Dave Moreland, Christine Humblet Pfizer Global
More informationEnhancing Specificity in the Janus Kinases: A Study on the Thienopyridine. JAK2 Selective Mechanism Combined Molecular Dynamics Simulation
Electronic Supplementary Material (ESI) for Molecular BioSystems. This journal is The Royal Society of Chemistry 2015 Supporting Information Enhancing Specificity in the Janus Kinases: A Study on the Thienopyridine
More informationDr. Sander B. Nabuurs. Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre
Dr. Sander B. Nabuurs Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre The road to new drugs. How to find new hits? High Throughput
More informationSupporting Information
S-1 Supporting Information Flaviviral protease inhibitors identied by fragment-based library docking into a structure generated by molecular dynamics Dariusz Ekonomiuk a, Xun-Cheng Su b, Kiyoshi Ozawa
More informationThermodynamic Integration with Enhanced Sampling (TIES)
Thermodynamic Integration with Enhanced Sampling (TIES) A. P. Bhati, S. Wan, D. W. Wright and P. V. Coveney agastya.bhati.14@ucl.ac.uk Centre for Computational Science Department of Chemistry University
More informationRetrieving hits through in silico screening and expert assessment M. N. Drwal a,b and R. Griffith a
Retrieving hits through in silico screening and expert assessment M.. Drwal a,b and R. Griffith a a: School of Medical Sciences/Pharmacology, USW, Sydney, Australia b: Charité Berlin, Germany Abstract:
More informationPose and affinity prediction by ICM in D3R GC3. Max Totrov Molsoft
Pose and affinity prediction by ICM in D3R GC3 Max Totrov Molsoft Pose prediction method: ICM-dock ICM-dock: - pre-sampling of ligand conformers - multiple trajectory Monte-Carlo with gradient minimization
More informationPrinciples of Drug Design
(16:663:502) Instructors: Longqin Hu and John Kerrigan Direct questions and enquiries to the Course Coordinator: Longqin Hu For more current information, please check WebCT at https://webct.rutgers.edu
More informationDifferent conformations of the drugs within the virtual library of FDA approved drugs will be generated.
Chapter 3 Molecular Modeling 3.1. Introduction In this study pharmacophore models will be created to screen a virtual library of FDA approved drugs for compounds that may inhibit MA-A and MA-B. The virtual
More informationMolecular Interactions F14NMI. Lecture 4: worked answers to practice questions
Molecular Interactions F14NMI Lecture 4: worked answers to practice questions http://comp.chem.nottingham.ac.uk/teaching/f14nmi jonathan.hirst@nottingham.ac.uk (1) (a) Describe the Monte Carlo algorithm
More informationBioengineering & Bioinformatics Summer Institute, Dept. Computational Biology, University of Pittsburgh, PGH, PA
Pharmacophore Model Development for the Identification of Novel Acetylcholinesterase Inhibitors Edwin Kamau Dept Chem & Biochem Kennesa State Uni ersit Kennesa GA 30144 Dept. Chem. & Biochem. Kennesaw
More informationArtificial Intelligence Methods for Molecular Property Prediction. Evan N. Feinberg Pande Lab
Artificial Intelligence Methods for Molecular Property Prediction Evan N. Feinberg Pande Lab AI Drug Discovery trends.google.com https://g.co/trends/3y4uf MNIST Performance over Time https://srconstantin.wordpress.com/2017/01/28/performance-trends-in-ai/
More informationDesign and Synthesis of the Comprehensive Fragment Library
YOUR INNOVATIVE CHEMISTRY PARTNER IN DRUG DISCOVERY Design and Synthesis of the Comprehensive Fragment Library A 3D Enabled Library for Medicinal Chemistry Discovery Warren S Wade 1, Kuei-Lin Chang 1,
More informationDispensing Processes Profoundly Impact Biological, Computational and Statistical Analyses
Dispensing Processes Profoundly Impact Biological, Computational and Statistical Analyses Sean Ekins 1, Joe Olechno 2 Antony J. Williams 3 1 Collaborations in Chemistry, Fuquay Varina, NC. 2 Labcyte Inc,
More informationNew approaches to scoring function design for protein-ligand binding affinities. Richard A. Friesner Columbia University
New approaches to scoring function design for protein-ligand binding affinities Richard A. Friesner Columbia University Overview Brief discussion of advantages of empirical scoring approaches Analysis
More informationDOCKING TUTORIAL. A. The docking Workflow
2 nd Strasbourg Summer School on Chemoinformatics VVF Obernai, France, 20-24 June 2010 E. Kellenberger DOCKING TUTORIAL A. The docking Workflow 1. Ligand preparation It consists in the standardization
More informationONETEP PB/SA: Application to G-Quadruplex DNA Stability. Danny Cole
ONETEP PB/SA: Application to G-Quadruplex DNA Stability Danny Cole Introduction Historical overview of structure and free energy calculation of complex molecules using molecular mechanics and continuum
More informationApplications of Fragment Based Approaches
Applications of Fragment Based Approaches Ben Davis Vernalis R&D, Cambridge UK b.davis@vernalis.com 1 Applications of Fragment Based Approaches creening fragment libraries Techniques Vernalis eeds approach
More informationWelcome to Week 5. Chapter 9 - Binding, Structure, and Diversity. 9.1 Intermolecular Forces. Starting week five video. Introduction to Chapter 9
Welcome to Week 5 Starting week five video Please watch the online video (49 seconds). Chapter 9 - Binding, Structure, and Diversity Introduction to Chapter 9 Chapter 9 contains six subsections. Intermolecular
More informationLigand Scout Tutorials
Ligand Scout Tutorials Step : Creating a pharmacophore from a protein-ligand complex. Type ke6 in the upper right area of the screen and press the button Download *+. The protein will be downloaded and
More informationPrinciples of Drug Design
Advanced Medicinal Chemistry II Principles of Drug Design Tentative Course Outline Instructors: Longqin Hu and John Kerrigan Direct questions and enquiries to the Course Coordinator: Longqin Hu I. Introduction
More informationToward an Understanding of GPCR-ligand Interactions. Alexander Heifetz
Toward an Understanding of GPCR-ligand Interactions Alexander Heifetz UK QSAR and ChemoInformatics Group Conference, Cambridge, UK October 6 th, 2015 Agenda Fragment Molecular Orbitals (FMO) for GPCR exploration
More informationUsing AutoDock for Virtual Screening
Using AutoDock for Virtual Screening CUHK Croucher ASI Workshop 2011 Stefano Forli, PhD Prof. Arthur J. Olson, Ph.D Molecular Graphics Lab Screening and Virtual Screening The ultimate tool for identifying
More informationMolecular Dynamics Graphical Visualization 3-D QSAR Pharmacophore QSAR, COMBINE, Scoring Functions, Homology Modeling,..
3 Conformational Search Molecular Docking Simulate Annealing Ab Initio QM Molecular Dynamics Graphical Visualization 3-D QSAR Pharmacophore QSAR, COMBINE, Scoring Functions, Homology Modeling,.. Rino Ragno:
More informationVolume 12(2)
Open access www.bioinformation.net Volume 12(2) Hypothesis Insights from molecular modeling, docking and simulation of imidazole nucleus containing chalcones with EGFR kinase domain for improved binding
More informationAlchemical free energy calculations in OpenMM
Alchemical free energy calculations in OpenMM Lee-Ping Wang Stanford Department of Chemistry OpenMM Workshop, Stanford University September 7, 2012 Special thanks to: John Chodera, Morgan Lawrenz Outline
More informationIsothermal Titration Calorimetry in Drug Discovery. Geoff Holdgate Structure & Biophysics, Discovery Sciences, AstraZeneca October 2017
Isothermal Titration Calorimetry in Drug Discovery Geoff Holdgate Structure & Biophysics, Discovery Sciences, AstraZeneca October 217 Introduction Introduction to ITC Strengths / weaknesses & what is required
More informationLecture for Molekylär bioinformatik X3 Feb Computational Chemistry in Drug Discovery. Mats Kihlén. Head of Research Informatics.
Lecture for Molekylär bioinformatik X3 Feb 24 2004 Computational Chemistry in Drug Discovery Mats Kihlén Head of Research Informatics Biovitrum AB verview» The role of computational chemistry» Basic concepts
More informationMM-PBSA Validation Study. Trent E. Balius Department of Applied Mathematics and Statistics AMS
MM-PBSA Validation Study Trent. Balius Department of Applied Mathematics and Statistics AMS 535 11-26-2008 Overview MM-PBSA Introduction MD ensembles one snap-shots relaxed structures nrichment Computational
More informationDe Novo molecular design with Deep Reinforcement Learning
De Novo molecular design with Deep Reinforcement Learning @olexandr Olexandr Isayev, Ph.D. University of North Carolina at Chapel Hill olexandr@unc.edu http://olexandrisayev.com About me Ph.D. in Chemistry
More informationPresentation Microcalorimetry for Life Science Research
Presentation Microcalorimetry for Life Science Research MicroCalorimetry The Universal Detector Heat is either generated or absorbed in every chemical process Capable of thermal measurements over a wide
More informationAdvanced Medicinal Chemistry SLIDES B
Advanced Medicinal Chemistry Filippo Minutolo CFU 3 (21 hours) SLIDES B Drug likeness - ADME two contradictory physico-chemical parameters to balance: 1) aqueous solubility 2) lipid membrane permeability
More informationBiologically Relevant Molecular Comparisons. Mark Mackey
Biologically Relevant Molecular Comparisons Mark Mackey Agenda > Cresset Technology > Cresset Products > FieldStere > FieldScreen > FieldAlign > FieldTemplater > Cresset and Knime About Cresset > Specialist
More informationVirtual Screening. Anna Linusson. Department of Chemistry Umeå University Sweden
Virtual Screening Anna Linusson Department of Chemistry Umeå University Sweden Virtual screening N N NH 2 N Cl N N H H H N N N S N HN N H S N N S S N N Free energy of binding + 0 0 G RT ln K A H T S 0
More informationCHAPTER 3. Pharmacophore modelling studies:
CHAPTER 3 Pharmacophore modelling studies: 3.1 Introduction: According to Langer & Wolber (2004), the key goal of computer-aided molecular design methods in medicinal chemistry is to reduce the time and
More informationQuantification of free ligand conformational preferences by NMR and their relationship to the bioactive conformation
Quantification of free ligand conformational preferences by NMR and their relationship to the bioactive conformation Charles Blundell charles.blundell@c4xdiscovery.com www.c4xdiscovery.com Rigid: single
More informationProtein-Ligand Docking Methods
Review Goal: Given a protein structure, predict its ligand bindings Protein-Ligand Docking Methods Applications: Function prediction Drug discovery etc. Thomas Funkhouser Princeton University S597A, Fall
More informationMEDICINAL CHEMISTRY Homework 2 - ANSWERS
MEDICIAL CEMISTY omework 2 - ASWES 1. eceptor binding curves. Make a plot of %drug-bound versus -log[drug] for a drug whose K D is 5 x 10-6 M. Make a plot of %drug-bound vs [drug] for this same system.
More informationStructure-Based Drug Discovery An Overview
Structure-Based Drug Discovery An Overview Edited by Roderick E. Hubbard University of York, Heslington, York, UK and Vernalis (R&D) Ltd, Abington, Cambridge, UK RSC Publishing Contents Chapter 1 3D Structure
More informationMinireview: Molecular Structure and Dynamics of Drug Targets
Prague Medical Report / Vol. 109 (2008) No. 2 3, p. 107 112 107) Minireview: Molecular Structure and Dynamics of Drug Targets Dahl S. G., Sylte I. Department of Pharmacology, Institute of Medical Biology,
More informationProblem Set 5 Question 1
2.32 Problem Set 5 Question As discussed in class, drug discovery often involves screening large libraries of small molecules to identify those that have favorable interactions with a certain druggable
More informationMolecular Similarity Searching Using Inference Network
Molecular Similarity Searching Using Inference Network Ammar Abdo, Naomie Salim* Faculty of Computer Science & Information Systems Universiti Teknologi Malaysia Molecular Similarity Searching Search for
More informationVirtual screening for drug discovery. Markus Lill Purdue University
Virtual screening for drug discovery Markus Lill Purdue University mlill@purdue.edu Lecture material http://people.pharmacy.purdue.edu/~mlill/teaching/eidelberg/ I.1 Drug discovery Cl N Disease I.1 Drug
More informationHomology Models of Human Adrenergic Receptors
58 Chapter 4 Homology Models of Human Adrenergic Receptors The increased availability of high-resolution GPCR crystal structures has enabled deeper investigation into homology modeling as a method for
More informationIntroductory Tutorial for the UCSF DOCK Program (v. 6.1)
Introductory Tutorial for the UCS DCK Program (v. 6.1) Author: John E. Kerrigan, Ph.D. University of Medicine & Dentistry of ew Jersey Robert Wood Johnson Medical School 675 oes Lane Piscataway, J 08854
More informationMedicinal Chemist s Relationship with Additivity: Are we Taking the Fundamentals for Granted?
Medicinal Chemist s Relationship with Additivity: Are we Taking the Fundamentals for Granted? J. Guy Breitenbucher Streamlining Drug Discovery Conference San Francisco, CA ct. 25, 2018 Additivity as the
More informationStructural Bioinformatics (C3210) Molecular Docking
Structural Bioinformatics (C3210) Molecular Docking Molecular Recognition, Molecular Docking Molecular recognition is the ability of biomolecules to recognize other biomolecules and selectively interact
More informationBinding Free Energy Calculations for Lead Optimization: Assessment of Their Accuracy in an Industrial Drug Design Context
pubs.acs.org/jctc Binding Free Energy Calculations for Lead Optimization: Assessment of Their Accuracy in an Industrial Drug Design Context Nadine Homeyer, Friederike Stoll, Alexander Hillisch, and Holger
More informationTowards Physics-based Models for ADME/Tox. Tyler Day
Towards Physics-based Models for ADME/Tox Tyler Day Overview Motivation Application: P450 Site of Metabolism Application: Membrane Permeability Future Directions and Applications Motivation Advantages
More informationComputational Chemistry in Drug Design. Xavier Fradera Barcelona, 17/4/2007
Computational Chemistry in Drug Design Xavier Fradera Barcelona, 17/4/2007 verview Introduction and background Drug Design Cycle Computational methods Chemoinformatics Ligand Based Methods Structure Based
More informationPlan. Day 2: Exercise on MHC molecules.
Plan Day 1: What is Chemoinformatics and Drug Design? Methods and Algorithms used in Chemoinformatics including SVM. Cross validation and sequence encoding Example and exercise with herg potassium channel:
More informationNMR study of complexes between low molecular mass inhibitors and the West Nile virus NS2B-NS3 protease
University of Wollongong Research Online Faculty of Science - Papers (Archive) Faculty of Science, Medicine and Health 2009 NMR study of complexes between low molecular mass inhibitors and the West Nile
More informationMOLECULAR DRUG TARGETS
MOLECULAR DRUG TARGETS LEARNING OUTCOMES At the end of this session student shall be able to: List different types of druggable targets Describe forces involved in drug-receptor interactions Describe theories
More informationProtein-Ligand Docking Methods
Review Goal: Given a protein structure, predict its ligand bindings Protein-Ligand Docking Methods Applications: Function prediction Drug discovery etc. Thomas Funkhouser Princeton University S597A, Fall
More informationDock Ligands from a 2D Molecule Sketch
Dock Ligands from a 2D Molecule Sketch March 31, 2016 Sample to Insight CLC bio, a QIAGEN Company Silkeborgvej 2 Prismet 8000 Aarhus C Denmark Telephone: +45 70 22 32 44 www.clcbio.com support-clcbio@qiagen.com
More informationThe mapping of a protein by experimental or computational tools
Computational mapping identifies the binding sites of organic solvents on proteins Sheldon Dennis, Tamas Kortvelyesi, and Sandor Vajda Department of Biomedical Engineering, Boston University, Boston, MA
More informationReceptor Based Drug Design (1)
Induced Fit Model For more than 100 years, the behaviour of enzymes had been explained by the "lock-and-key" mechanism developed by pioneering German chemist Emil Fischer. Fischer thought that the chemicals
More informationA Rational Approach to Receptor-Flexible Docking: Method and Validation
For audio: Dial-in Information: Toll Free +1 (866) 519 8942 Toll +1 (770) 790 2186 Participant Code: 8587995760 ctober 2007 A Rational Approach to Receptor-Flexible Docking: Method and Validation C. M.
More information*Corresponding Author *K. F.: *T. H.:
Theoretical Analysis of Activity Cliffs among Benzofuranone Class Pim1 Inhibitors Using the Fragment Molecular Orbital Method with Molecular Mechanics Poisson-Boltzmann Surface Area (FMO+MM-PBSA) Approach
More informationSUPPLEMENTARY INFORMATION
doi:10.1038/nature11085 Supplementary Tables: Supplementary Table 1. Summary of crystallographic and structure refinement data Structure BRIL-NOP receptor Data collection Number of crystals 23 Space group
More informationChemogenomic: Approaches to Rational Drug Design. Jonas Skjødt Møller
Chemogenomic: Approaches to Rational Drug Design Jonas Skjødt Møller Chemogenomic Chemistry Biology Chemical biology Medical chemistry Chemical genetics Chemoinformatics Bioinformatics Chemoproteomics
More informationCreating a Pharmacophore Query from a Reference Molecule & Scaffold Hopping in CSD-CrossMiner
Table of Contents Creating a Pharmacophore Query from a Reference Molecule & Scaffold Hopping in CSD-CrossMiner Introduction... 2 CSD-CrossMiner Terminology... 2 Overview of CSD-CrossMiner... 3 Features
More informationJonathan S. Mason,, Isabelle Morize, Paul R. Menard,*, Daniel L. Cheney, Christopher Hulme, and Richard F. Labaudiniere
J. Med. Chem. 1999, 42, 3251-3264 3251 New 4-Point Pharmacophore Method for Molecular Similarity and Diversity Applications: Overview of the Method and Applications, Including a Novel Approach to the Design
More informationHomology modeling. Dinesh Gupta ICGEB, New Delhi 1/27/2010 5:59 PM
Homology modeling Dinesh Gupta ICGEB, New Delhi Protein structure prediction Methods: Homology (comparative) modelling Threading Ab-initio Protein Homology modeling Homology modeling is an extrapolation
More informationA primer on pharmacology pharmacodynamics
A primer on pharmacology pharmacodynamics Drug binding & effect Universidade do Algarve Faro 2017 by Ferdi Engels, Ph.D. 1 Pharmacodynamics Relation with pharmacokinetics? dosage plasma concentration site
More informationMedicinal Chemistry/ CHEM 458/658 Chapter 4- Computer-Aided Drug Design
Medicinal Chemistry/ CHEM 458/658 Chapter 4- Computer-Aided Drug Design Bela Torok Department of Chemistry University of Massachusetts Boston Boston, MA 1 Computer Aided Drug Design - Introduction Development
More informationPing-Chiang Lyu. Institute of Bioinformatics and Structural Biology, Department of Life Science, National Tsing Hua University.
Pharmacophore-based Drug design Ping-Chiang Lyu Institute of Bioinformatics and Structural Biology, Department of Life Science, National Tsing Hua University 96/08/07 Outline Part I: Analysis The analytical
More informationSpacer conformation in biologically active molecules*
Pure Appl. Chem., Vol. 76, No. 5, pp. 959 964, 2004. 2004 IUPAC Spacer conformation in biologically active molecules* J. Karolak-Wojciechowska and A. Fruziński Institute of General and Ecological Chemistry,
More informationProtein structure based approaches to inhibit Plasmodium DHODH for malaria
Protein structure based approaches to inhibit Plasmodium DHDH for malaria Peter Johnson University of Leeds, School of Chemistry email p.johnson@leeds.ac.uk Tools for protein structure based approaches
More informationA Tiered Screen Protocol for the Discovery of Structurally Diverse HIV Integrase Inhibitors
A Tiered Screen Protocol for the Discovery of Structurally Diverse HIV Integrase Inhibitors Rajarshi Guha, Debojyoti Dutta, Ting Chen and David J. Wild School of Informatics Indiana University and Dept.
More informationβ1 Structure Prediction and Validation
13 Chapter 2 β1 Structure Prediction and Validation 2.1 Overview Over several years, GPCR prediction methods in the Goddard lab have evolved to keep pace with the changing field of GPCR structure. Despite
More informationChemical library design
Chemical library design Pavel Polishchuk Institute of Molecular and Translational Medicine Palacky University pavlo.polishchuk@upol.cz Drug development workflow Vistoli G., et al., Drug Discovery Today,
More informationTargeting protein-protein interactions: A hot topic in drug discovery
Michal Kamenicky; Maria Bräuer; Katrin Volk; Kamil Ödner; Christian Klein; Norbert Müller Targeting protein-protein interactions: A hot topic in drug discovery 104 Biomedizin Innovativ patientinnenfokussierte,
More informationschematic diagram; EGF binding, dimerization, phosphorylation, Grb2 binding, etc.
Lecture 1: Noncovalent Biomolecular Interactions Bioengineering and Modeling of biological processes -e.g. tissue engineering, cancer, autoimmune disease Example: RTK signaling, e.g. EGFR Growth responses
More informationStructure-Activity Modeling - QSAR. Uwe Koch
Structure-Activity Modeling - QSAR Uwe Koch QSAR Assumption: QSAR attempts to quantify the relationship between activity and molecular strcucture by correlating descriptors with properties Biological activity
More informationImplementation of novel tools to facilitate fragment-based drug discovery by NMR:
Implementation of novel tools to facilitate fragment-based drug discovery by NMR: Automated analysis of large sets of ligand-observed NMR binding data and 19 F methods Andreas Lingel Global Discovery Chemistry
More informationSupplementary Methods
Supplementary Methods MMPBSA Free energy calculation Molecular Mechanics/Poisson Boltzmann Surface Area (MM/PBSA) has been widely used to calculate binding free energy for protein-ligand systems (1-7).
More informationEMPIRICAL VS. RATIONAL METHODS OF DISCOVERING NEW DRUGS
EMPIRICAL VS. RATIONAL METHODS OF DISCOVERING NEW DRUGS PETER GUND Pharmacopeia Inc., CN 5350 Princeton, NJ 08543, USA pgund@pharmacop.com Empirical and theoretical approaches to drug discovery have often
More informationOther Cells. Hormones. Viruses. Toxins. Cell. Bacteria
Other Cells Hormones Viruses Toxins Cell Bacteria ΔH < 0 reaction is exothermic, tells us nothing about the spontaneity of the reaction Δ H > 0 reaction is endothermic, tells us nothing about the spontaneity
More information